EC Number |
Protein Variants |
Reference |
---|
1.1.1.153 | D257H |
mutant shows completely inhibited sepiapterin reduction. Mutation has only minimal effects on redox cycling |
725527 |
1.1.1.153 | DELTA257-261 |
deletion of the C-terminal 5 amino acids almost completely eliminates enzyme activity. For redox cycling, the catalytic efficacy decreases to less than 1% of the wild type enzyme |
725527 |
1.1.1.153 | F99A |
the mutant shows 3.9fold higher Km and lower Vmax (8.95%) than the wild type enzyme |
695294 |
1.1.1.153 | G14S |
mutations in Gly14 and Gly18 in the NADPH binding motif of sepiapterin reductase results in almost complete loss of the ability to reduce sepiapterin, and a 65-75% decrease in redox cycling. For both of these mutations, the catalytic efficiencies for redox cycling decreases to 0.2% of wild type sepiapterin reductase |
725527 |
1.1.1.153 | G18D |
mutations in Gly14 and Gly18 in the NADPH binding motif of sepiapterin reductase results in almost complete loss of the ability to reduce sepiapterin, and a 65-75% decrease in redox cycling. For both of these mutations, the catalytic efficiencies for redox cycling decreases to 0.2% of wild type sepiapterin reductase |
725527 |
1.1.1.153 | K174L |
catalytic efficiencies (Kcat/Km) for sepiapterin reduction of S157A mutant and K174L mutant decreases to 1.8% and 0.8% of wild type sepiapterin reductase, respectively, and for redox cycling to 6.8% and 1.4%, respectively |
725527 |
1.1.1.153 | K175I |
decreased activity against a pteridine substrate and exogenous carbonyl compound |
286028 |
1.1.1.153 | K251X |
naturally occurring mutation in gene SPR, exon 3, causing enzyme deficiency |
668883 |
1.1.1.153 | M205G |
mutation leads to marked reductions in the activities of both sepiapterin reduction and redox cycling. The catalytic efficiency of N99A and M205G for sepiapterin reduction decreases to approximately 1% and 5%, respectively, and for redox cycling, 5% and 25%, respectively, when compared to the wild type enzyme |
725527 |
1.1.1.153 | more |
a single nucleotide polymorphism around the SPR gene is involved in development of Parkonson's disease |
685875 |